Tuesday, February 26, 2013
DelMar Pharmaceuticals Inc., of Vancouver, British Columbia, said it completed the fourth closing in a private placement consisting of approximately 2 million units of its securities to qualified accredited investors, for gross proceeds of approximately $1.6 million.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.